Market Cap
$2.3B
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
$4.41 ▲ +4.14%
Prev close $4.23Market cap$2.3B
ConsensusBuy
12-mo target$5.38 (+22.0%)
▲ Bullish
Analyst conviction 6/10
Insider Selling Cluster (4 insiders)High Impact Filing (7/10)20 New Institutional Positions11 Institutional Exits Traditional Finance
Snapshot
The big-picture read on CLOV right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Buy (60%)
Inst. Holders
50 funds
Inst. Value
$765.1M
Inst. Activity
20 buys / 11 sells
Insider Activity
$0.00 buy / $6.6M sell
Insider Net $
-$6.6M
Social Sentiment
65° Warm
SEC Reports
16
Press Releases
2
Price chart 30d +2.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 24, 2026 other
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Mi
Sep 17, 2026 Insider
Sep 16, 2026 SEC Reynoso Jamie L. sold 1,921 shares
CEO, Medicare Advantage @ $4.56 ($8.8K)
Two insider sells totaling $148K were reported for Clover Health Investments, Corp. (CLOV), representing a trivial fract
CLUSTER — Impact 2/10
Sep 16, 2026 Insider
OLDAKOWSKI JOSEPH FRANK sold 3,170 shares
VP OF FINANCE AND CONTROLLER @ $4.64 ($14.7K)
Sep 15, 2026 Insider
Aug 17, 2026 SEC Reynoso Jamie L. sold 9,273 shares
CEO, Medicare Advantage @ $4.78 ($44.3K)
Two C-suite insiders at Clover Health sold a combined $486K in open-market sales within a week, including the CEO sellin
CLUSTER — Impact 5/10
The court consolidated four putative class actions against Clover Health into a single data breach litigation (In re Clo
COURT-RULING — Impact 4/10
Aug 11, 2026 Event
Homan v. Clover Health Investments, Corp.
Court ruling (tnmd) — Docket: 3:26-cv-01047
Analyst ratings buy % -10.4%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
60% rate it Buy or better · 10 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 6, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jul 21, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Jun 11, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Jun 4, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Aug 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Jul 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Jun 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| May 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Apr 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Mar 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Feb 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% |
Price targets
Where 4 covering analysts think CLOV trades over the next 12 months.
$5.38 +22.0% upside Strong Buy
Current$4.41 Low$5.00 Median$5.25 High$6.00 4 analysts
$5.00$6.00
Analyst rating None as of Oct 2, 2026
Social media sentiment mood +20.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
65°
Warm
BearishNeutralBullish
Recent posts
https://stocktwits.com/news-articles/markets/equity/clov-stock-humana-deal-buzz-ahead-of-investor-conferences/cZtVuUhRBTQ
▲ 1 · 💬 1· ⚡ 0.5
CLOV
▲ 1 · 💬 0· ⚡ 0.5
Roast my stock picks and tell me if you'd invest.
▲ 1 · 💬 1· ⚡ 0.5
$CLOV challenged the CMS star rating and got 4.5stars…announced today.
▲ 1 · 💬 0· ⚡ 0.5
$CLOV — Clover Health just posted their first profitable quarter ever and nobody's talking about it
▲ 1 · 💬 0· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
16 SEC filing reports analyzed · 1 bullish, 3 bearish, 0 mixed, 12 neutral · avg impact 3.4/10.Plus 2 press releases.
NEUTRALCLUSTER2/10
Two insider sells totaling $148K were reported for Clover Health Investments, Corp. (CLOV), represen
Sep 16, 2026
BEARISHCLUSTER5/10
Two C-suite insiders at Clover Health sold a combined $486K in open-market sales within a week, incl
Aug 17, 2026
NEUTRALCOURT-RULING4/10
The court consolidated four putative class actions against Clover Health into a single data breach l
Aug 14, 2026
NEUTRALCLUSTER3/10
Five CLOV insiders, including the CEO, CEO of Medicare Advantage, CEO of Counterpart Health, Chief L
Jul 20, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 24, 2026
other
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
Sep 24, 2026
other
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
Sep 24, 2026
short_volume
Short Volume: CLOV — 57.3% short (0.8M / 1.4M)
Short: 811,177 | Exempt: 2 | TRF Vol: 1,416,783 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
Sep 21, 2026
short_volume
Short Volume: CLOV — 55.0% short (0.6M / 1.1M)
Short: 632,074 | Exempt: 213 | TRF Vol: 1,148,296 | Short Ratio: 55.0% | Off-exchange volume (dark pool + OTC)
Aug 31, 2026
other
Clover Health to Participate in Upcoming Investor Conferences
Clover Health to Participate in Upcoming Jefferies & Deutsche Bank Investor Conferences
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.01 | $0.01–$0.01 | 203.0% | — | 0↑ 1↓ | $0.7B | 1 |
| Next Q | $-0.02 | $-0.02–$-0.02 | 56.4% | +33.3% | 0↑ 1↓ | $0.7B | 1 |
| Current FY | $0.14 | $0.14–$0.14 | 259.0% | +0.0% | 0↑ 1↓ | $3.0B | 1 |
| Next FY | $0.15 | $0.15–$0.15 | 7.1% | +0.0% | 0↑ 1↓ | $3.5B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.010 | — |
| 7d ago | $0.000 | +0.010 |
| 30d ago | $0.000 | +0.010 |
| 60d ago | $0.000 | +0.010 |
| 90d ago | $0.000 | +0.010 |
Institutional ownership
Which big funds own CLOV (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $765.1M total value (145,979,663 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, GEODE. Net buying activity: 20 institutions added/increased vs 11 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 35,106,965 | $184.0M | 24.0% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 18,037,661 | $94.5M | 12.4% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 10,846,066 | $56.8M | 7.4% | — |
| STATE STREET CORP | 10,180,337 | $53.3M | 7.0% | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 7,205,400 | $37.8M | 4.9% | NEAR_EXIT -79.4% |
| Nuveen, LLC | 6,291,699 | $33.0M | 4.3% | DOUBLED +572.5% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 5,521,188 | $28.9M | 3.8% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,470,452 | $23.4M | 3.1% | — |
| NORTHERN TRUST CORP | 3,772,600 | $19.8M | 2.6% | — |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,563,874 | $18.7M | 2.4% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Nuveen, LLC | DOUBLED | 935,543 | 6,291,699 | +572.5% | $33.0M |
| D. E. Shaw & Co., Inc. | DOUBLED | 91,011 | 1,965,493 | +2059.6% | $10.3M |
| GOLDMAN SACHS GROUP INC | TRIM | 2,165,562 | 1,170,742 | -45.9% | $6.1M |
| Point72 Asset Management, L.P. | DOUBLED | 503,005 | 1,069,645 | +112.7% | $5.6M |
| GROUP ONE TRADING LLC | ADD | 587,104 | 747,239 | +27.3% | $3.9M |
| IMC-Chicago, LLC | ADD | 492,898 | 643,030 | +30.5% | $3.4M |
| UBS Group AG | NEAR_EXIT | 1,767,799 | 409,450 | -76.8% | $2.1M |
| WELLS FARGO & COMPANY/MN | DOUBLED | 156,874 | 395,057 | +151.8% | $2.1M |
| TUDOR INVESTMENT CORP ET AL | ADD | 191,361 | 276,123 | +44.3% | $1.4M |
| CITIGROUP INC | DOUBLED | 36,084 | 223,265 | +518.7% | $1.2M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 50 transactions. Net -$6.6M — $0.00 bought, $6.6M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 1,921 | $4.56 | $8.8K |
| Sep 16, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | SELL | 3,170 | $4.64 | $14.7K |
| Sep 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | SELL | 9,273 | $4.78 | $44.3K |
| Sep 15, 2026 | Soares Karen | Chief Legal Officer | SELL | 6,846 | $4.78 | $32.7K |
| Sep 15, 2026 | Wai Conrad | CEO, Counterpart Health | SELL | 300,000 | $4.72 | $1.4M |
| Sep 14, 2026 | OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | SELL | 20,000 | $5.16 | $103.2K |
| Aug 17, 2026 | THORNTON JOSEPH CLAY | Interim CFO | SELL | 17,775 | $4.39 | $78.0K |
| Aug 12, 2026 | THORNTON JOSEPH CLAY | Interim CFO | AWARD | 54,347 | — | — |
| Aug 12, 2026 | Soares Karen | Chief Legal Officer | AWARD | 108,695 | — | — |
| Aug 10, 2026 | Toy Andrew | Chief Executive Officer | SELL | 87,798 | $4.65 | $408.3K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CLOV.
Shares short
23,446,183
Settlement Sep 15, 2026
Change vs prior
-1.0%
Semi-monthly cycle
Days to cover
5.2
At avg daily volume
Of shares outstanding
≈4.4%
Estimate — not % of float
All CLOV filing & press-release reports (18)
- CLUSTER reportSep 16, 2026
- CLUSTER reportAug 17, 2026
- COURT-RULING reportAug 14, 2026
- CLUSTER reportJul 20, 2026
- CLUSTER reportJul 18, 2026
- CLUSTER reportJul 17, 2026
- CLUSTER reportJul 16, 2026
- CLUSTER reportJul 10, 2026
- CLUSTER reportJul 6, 2026
- CLUSTER reportJun 17, 2026
- 8-K reportJun 16, 2026
- CLUSTER reportJun 16, 2026
- 8-K reportJun 10, 2026
- CLUSTER reportMay 19, 2026
- 144 reportMay 14, 2026
- PRESS-RELEASE reportApr 8, 2026
- PRESS-RELEASE reportApr 7, 2026
- PRESS-RELEASE reportApr 1, 2026